National Laboratory on Clinical Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing 101149, China
Su-ting CHEN,Yu-hong FU,Li-ping ZHAO,Yi XUE,Hai-rong HUANG. Analysis of distribution and drug resistance of pulmonary TB patients with concurrent extrapulmonary TB[J]. Chinese Journal of Antituberculosis, 2018, 40(9): 964-968. doi: 10.3969/j.issn.1000-6621.2018.09.011
Qian X, Nguyen DT, Lyu J , et al. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis. Emerg Microbes Infect, 2018,7(1):102.
doi: 10.1038/s41426-018-0106-1URL
[9]
Lin CY, Chen TC, Lu PL , et al. Effects of gender and age on development of concurrent extrapulmonary tuberculosis in patients with pulmonary tuberculosis: a population based study. PLoS One, 2013,8(5):e63936.
doi: 10.1371/journal.pone.0063936URL
[10]
Sotgiu G, Falzon D, Hollo V , et al. Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014. PLoS One, 2017,12(11):e0186499.
doi: 10.1371/journal.pone.0186499URL